Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |